Bully to the Washington Post for publishing the anonymous op-ed by the lawyer who received one of the FBI’s national security letters. Remember, this guy wasn’t even under suspicion. One of his clients was (though apparently, not anymore). Nevertheless, his life was was thrown into disarray. Jim Henley’s right–here’s the most disturbing passage of an already disturbing essay:
Living under the gag order has been stressful and surreal. Under the threat of criminal prosecution, I must hide all aspects of my involvement in the case — including the mere fact that I received an NSL — from my colleagues, my family and my friends. When I meet with my attorneys I cannot tell my girlfriend where I am going or where I have been. I hide any papers related to the case in a place where she will not look. When clients and friends ask me whether I am the one challenging the constitutionality of the NSL statute, I have no choice but to look them in the eye and lie.
Requiring people to become secret informers is not a hallmark of a free society.
The Recording Industry Association of America (RIAA) are a bunch of music pirates that extort money to line their own pockets from people who cannot afford to defend themselves from barratry and who are accused of the awful sin of unauthorized listening to music.
Not that I have a strong opinion about them or anything.
Chuck Dupree has more.
Update: Xeni Jardin writes about the RIAA going after a ten-year-old girl (seven when she’s alleged to have done the dirty downloading deed).
Researchers investigating the role of cannabis in cancer therapy reveal it has the potential to destroy leukaemia cells, in a paper published in the March 2006 edition of Letters in Drug Design & Discovery. Led by Dr Wai Man Liu, at Barts and the London, Queen Mary’s School of Medicine and Dentistry, the team has followed up on their findings of 2005 which showed that the main active ingredient in cannabis, tetrahydrocannabinol, or THC, has the potential to be used effectively against some forms of cancer. Dr Liu has since moved to the Institute of Cancer in Sutton where he continues his work into investigating the potential therapeutic benefit of new anti-cancer agents.
It has previously been acknowledged that cannabis-based medicines have merit in the treatment of cancer patients as a painkiller; appetite stimulant and in reducing nausea, but recently evidence has been growing of its potential as an anti-tumour agent. The widely reported psychoactive side effects and consequent legal status of cannabis have, however, complicated its use in this capacity. Although THC and its related compounds have been shown to attack cancer cells by interfering with important growth-processing pathways, it has not hitherto been established exactly how this is achieved.
Now Dr Liu and his colleagues, using highly sophisticated microarray technology – allowing them to simultaneously detect changes in more than 25,000 genes in cells treated with THC – have begun to uncover further the existence of crucial processes through which THC can kill cancer cells and potentially promote survival. Further, Dr Liu found that the mechanism of cannabis may be independent of the presence of receptors – proteins found on the surface of cells to which other signalling molecules bind. Binding of molecules to receptors elicits a response in the cell, be it growth or death. The finding that cannabis action may not require the presence of these receptors introduces the possibility that the drug may be used more widely as the cancer cell’s dependence on the cannabis receptor is removed.
Whilst leukaemia treatment is on the whole successful, some people cannot be treated with conventional therapy – 25 per cent of children with leukaemia fail to respond to traditional treatment leaving their prognosis outcome poor. Dr Liu’s research findings provide a crucial first step towards the development of new therapies that can eradicate a deadly disease which affects millions of children and adults worldwide.
Dr Liu said: “It is important to stress that these cannabis-like substances are far removed from the cannabis that is smoked. These novel compounds have been specifically designed to be free of the psychoactive features, whilst maintaining anti-cancer action. Ultimately, understanding the fundamental mechanisms of these compounds will provide us with insights into developing new drugs that can be used to effectively treat cancers.”
For further information, please contact:
Senior Communications Officer
Queen Mary, University of London
Tel: +44 (0) 20 7882 7910